Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alchymars ICM SM Private Limited is a prominent Indian pharmaceutical company focused on the development and manufacture of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. Formed as a strategic joint venture between Alchymars and the Italian group ICM (International Chemical Management), the company operates high-capacity manufacturing sites in Chennai that adhere to global quality standards including USFDA and EUGMP. Their core expertise lies in the production of macrolide antibiotics, such as Azithromycin and Clarithromycin, alongside a robust portfolio of antihistamines like Ebastine. The company provides comprehensive contract development and manufacturing (CDMO) services, supporting global pharmaceutical firms from process development to commercial-scale production. With a strong emphasis on R&D and regulatory compliance, Alchymars ICM has established itself as a reliable supplier in the international life sciences supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alchymars ICM.